National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 12368-12369 [E9-6469]
Download as PDF
<![CDATA[
12368
Federal Register / Vol. 74, No. 55 / Tuesday, March 24, 2009 / Notices
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued
Annual
Frequency
per Response
No. of
Respondents
21 CFR Section
Total Annual
Responses
Hours per
Response
Total Hours
203.37(b)
50
40
2,000
.25
500
203.37(c)
1
1
1
1
1
203.37(d)
50
1
50
.08
4
203.39(g)
1
1
1
1
1
Total
1There
2,285,535.50
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
Annual Frequency
per
Recordkeeping
No. of
Recordkeepers
21 CFR Section
Total Annual
Records
Hours per
Record
Total Hours
203.23(a) and (b)
31,676
5
158,380
.25
39,595
203.23(c)
31,676
5
158,380
.08
12,670
203.30(a)(2) and 203.31(a)(2)
2,208
100
220,800
.50
110,400
203.31(d)(1) and (d)(2)
2,208
1
2,208
40
88,320
442
1
442
24
10,608
2,208
1
2,208
1
2,208
203.34
90
1
90
40
3,600
203.37(a)
50
4
200
6
1,200
203.37(b)
50
40
2,000
6
12,000
203.39(d)
65
1
65
1
65
203.39(e)
3,221
1
3,221
.50
1,610
203.39(f)
3,221
1
3,221
8
25,768
203.39(g)
3,221
1
3,221
8
25,768
203.50(a)
0
0
0
0
0
203.50(b)
0
0
0
0
0
203.50(d)
0
0
0
0
0
203.31(d)(4)
203.31(e)
Total
1There
324,092
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: March 17, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–6394 Filed 3–23–09; 8:45 am]
mstockstill on PROD1PC66 with NOTICES
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
VerDate Nov<24>2008
01:06 Mar 24, 2009
Jkt 217001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. Vaccine Design PO1.
Date: April 16, 2009.
E:\FR\FM\24MRN1.SGM
24MRN1
Federal Register / Vol. 74, No. 55 / Tuesday, March 24, 2009 / Notices
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Kenneth E. Santora, PhD.,
Scientific Review Officer, Scientific Review
Program, NIH/NIAID/DHHS, Room 3146,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892, 301–451–2605. ks216i@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–6469 Filed 3–23–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Heart Pumps for Children with
Cardiomyopathy.
Date: April 14, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Crystal City Reagan National
Airport, 2399 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Robert Blaine Moore, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7213,
Bethesda, MD 20892, 301–594–8394,
mooreb@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Characterizing the Blood Stem Cell Niche.
Date: April 23, 2009.
Time: 8 a.m. to 5 p.m.
VerDate Nov<24>2008
01:06 Mar 24, 2009
Jkt 217001
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Robert T. Su, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7202,
Bethesda, MD 20892–7924, 301–435–0297,
sur@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Loan Repayment Program (L30’s).
Date: April 30, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Rina Das, PhD, Scientific
Review Officer, Review Branch/DERA,
National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Room 7200, Bethesda,
MD 20892–7924, 301–435–0297,
dasr2@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–6476 Filed 3–23–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel. 2009 New Innovator Award PreApplication Review.
Date: April 22, 2009.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
12369
Time: 7 a.m. to 11:59 p.m.
Agenda: To review and evaluate review of
2009 New Innovator pre-applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Virtual Meeting).
Contact Person: Richard T. Okita, PhD,
Program Director, Pharmacological and
Physiological Sciences Branch, National
Institute of General Medical Sciences,
National Institutes of Health, Natcher
Building, Room 2AS–49, Bethesda, MD
20892, 301–594–4469. okitar@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: March 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–6470 Filed 3–23–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. Bioinformatics Resource
Centers for Infectious Diseases.
Date: April 22, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institutes of Health/NIAID, 6700B Rockledge
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 74, Number 55 (Tuesday, March 24, 2009)]
[Notices]
[Pages 12368-12369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6469]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel. Vaccine Design PO1.
Date: April 16, 2009.
[[Page 12369]]
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Kenneth E. Santora, PhD., Scientific Review
Officer, Scientific Review Program, NIH/NIAID/DHHS, Room 3146, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-451-2605.
ks216i@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-6469 Filed 3-23-09; 8:45 am]
BILLING CODE 4140-01-P
